RESEARCH USE ONLY. UK DISPATCH. ≥98% PURITY. SAME DAY DISPATCH BEFORE 2 PM MON–FRI. NOT FOR HUMAN CONSUMPTION
Lynx Peptides
Basket 0

Limited human evidence

Semax research overview

Review the published research context, areas studied and evidence limitations associated with this catalogue material.

Evidence context statedSources linkedLast reviewed

Research context

Small clinical studies have investigated Semax, an ACTH-derived peptide fragment, in neurological research settings using functional, electrophysiological and quality-of-life measures.

Areas studied

  • Neurological functional measures
  • Electrophysiological observations
  • Neurotrophin-related biomarkers
  • Quality-of-life measures

Limitations and investigational status

The cited studies are small, older or published in Russian-language journals, and include non-randomised or open-label designs. Findings are mixed and lack robust independent replication.

References

  1. 1Gusev et al. - Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova, 1997
  2. 2Serdiuk et al. - Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova, 2007

For laboratory research use only. Information presented here summarises areas investigated in published research and is not intended as medical advice or as evidence of established effects in humans.